Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination through Repressing p38MAPK Signaling
陳肇閎
陳肇閎
Categories: Journal  /   SCI(Sciences Citation Index)  /  
Year2022
Author
Created date2022-05-16
Author orderFirst author
Corresponding authorNo
Publication year2022
Publication month5
Journal nameVaccines
Publication area瑞士聯邦
Volume10
Issue5
Start page715
Review systemYes
LanguageTraditional Chinese